"G1 Phase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The period of the CELL CYCLE preceding DNA REPLICATION in S PHASE. Subphases of G1 include "competence" (to respond to growth factors), G1a (entry into G1), G1b (progression), and G1c (assembly). Progression through the G1 subphases is effected by limiting growth factors, nutrients, or inhibitors.
Descriptor ID |
D016193
|
MeSH Number(s) |
G04.144.500.320
|
Concept/Terms |
G1 Phase- G1 Phase
- G1 Phases
- Phase, G1
- Phases, G1
- First Gap Phase
- First Gap Phases
- Gap Phase, First
- Gap Phases, First
- Phase, First Gap
- Phases, First Gap
- Gap Phase 1
- Phase 1, Gap
G1b Phase- G1b Phase
- G1b Phases
- Phase, G1b
- Phases, G1b
G1a Phase- G1a Phase
- G1a Phases
- Phase, G1a
- Phases, G1a
|
Below are MeSH descriptors whose meaning is more general than "G1 Phase".
Below are MeSH descriptors whose meaning is more specific than "G1 Phase".
This graph shows the total number of publications written about "G1 Phase" by people in this website by year, and whether "G1 Phase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2006 | 0 | 3 | 3 |
2008 | 0 | 2 | 2 |
2009 | 1 | 1 | 2 |
2015 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "G1 Phase" by people in Profiles.
-
Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin. Int J Biol Macromol. 2019 Feb 01; 122:1100-1114.
-
Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR. Mol Cancer Ther. 2017 08; 16(8):1470-1486.
-
Tideglusib induces apoptosis in human neuroblastoma IMR32 cells, provoking sub-G0/G1 accumulation and ROS generation. Environ Toxicol Pharmacol. 2016 Sep; 46:194-205.
-
Understanding thrombocytopenia: physiological role of microRNA in survival of neonatal megakaryocytes. J Thromb Thrombolysis. 2015 Oct; 40(3):310-6.
-
Anti-tumor activity of a new series of benzoxazepine derivatives in breast cancer. Bioorg Med Chem Lett. 2010 Jan 01; 20(1):283-7.
-
Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Cancer Res. 2009 Aug 15; 69(16):6565-72.
-
Activation of apoptosis by 1-hydroxy-5,7-dimethoxy-2-naphthalene-carboxaldehyde, a novel compound from Aegle marmelos. Cancer Res. 2008 Oct 15; 68(20):8573-81.
-
Knockdown of MBP-1 in human foreskin fibroblasts induces p53-p21 dependent senescence. PLoS One. 2008; 3(10):e3384.
-
Downregulation of PCNA potentiates p21-mediated growth inhibition in response to hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2007 Mar; 292(3):L716-24.
-
The reversibility of mitotic exit in vertebrate cells. Nature. 2006 Apr 13; 440(7086):954-8.